These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7112506)

  • 1. Studies on a highly active anticoagulant fraction of high molecular weight isolated from porcine sodium heparin.
    Sache E; Maillard M; Bertrand H; Maman M; Kunz M; Choay J; Fareed J; Messmore H
    Thromb Res; 1982 Mar; 25(6):443-58. PubMed ID: 7112506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on a highly potent anticoagulant anionic high molecular weight fraction isolated from porcine heparin.
    Sache E; Choay J; Fareed J
    Ann N Y Acad Sci; 1981; 370():627-43. PubMed ID: 6943973
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence for a plasma inhibitor of the heparin accelerated inhibition of factor Xa by antithrombin III.
    MacGregor IR; Lane DA; Kakkar VV
    Biochim Biophys Acta; 1979 Sep; 586(3):584-93. PubMed ID: 476156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High and low anticoagulant activity heparins. Preparation in large scale and degree of complexation with antithrombin III.
    Takahashi HK; Nader HB; Dietrich CP
    Arzneimittelforschung; 1985; 35(11):1620-3. PubMed ID: 4091864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Separation of heparin into fractions with different anticoagulant activity by hydrophobic interaction chromatography.
    Ogamo A; Uchiyama H; Nagasawa K
    Biochim Biophys Acta; 1980 Dec; 626(2):477-85. PubMed ID: 7213665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding to antithrombin of heparin fractions with different molecular weights.
    Danielsson A; Björk I
    Biochem J; 1981 Feb; 193(2):427-33. PubMed ID: 7305940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulant activities of high and low molecular weight heparin fractions.
    Barrowcliffe TW; Johnson EA; Eggleton CA; Kemball-Cook G; Thomas DP
    Br J Haematol; 1979 Apr; 41(4):573-83. PubMed ID: 435404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement inhibitory and anticoagulant activities of fractionated heparins.
    Hennink WE; Klerx JP; van Dijk H; Feijen J
    Thromb Res; 1984 Nov; 36(4):281-92. PubMed ID: 6523441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of low molecular weight heparin effect on the relation between anticoagulant activity and antithrombin III affinity.
    Hamano S; Nishiyama M; Kikuchi S; Komatsu H; Miyata H; Ikeda S; Sakuragawa N
    Thromb Res; 1992 May; 66(4):299-307. PubMed ID: 1329257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elimination of high affinity heparin fractions and their anticoagulant and lipase activity.
    de Swart CA; Nijmeyer B; Andersson LO; Holmer E; Verschoor L; Bouma BN; Sixma JJ
    Blood; 1984 Apr; 63(4):836-42. PubMed ID: 6704544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological activities of heparins obtained from different tissues: enrichment of heparin fractions with high lipoprotein lipase, antihemolytic and anticoagulant activities by molecular sieving and antithrombin III affinity chromatography.
    Bianchini P; Osima B; Parma B; Nader HB; Dietrich CP
    J Pharmacol Exp Ther; 1982 Feb; 220(2):406-10. PubMed ID: 7057400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative activities of heparin fractions obtained by gel chromatography.
    Graham DT; Pomeroy AR
    Thromb Haemost; 1980 Feb; 42(5):1598-603. PubMed ID: 7368160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulant and antithrombotic effects of heparin and low molecular weight heparin fragments in rabbits.
    Holmer E; Mattsson C; Nilsson S
    Thromb Res; 1982 Mar; 25(6):475-85. PubMed ID: 7112507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the in vivo hemorrhagic and antithrombotic effects of a low antithrombin-III affinity heparin fraction.
    Ockelford PA; Carter CJ; Cerskus A; Smith CA; Hirsh J
    Thromb Res; 1982 Sep; 27(6):679-90. PubMed ID: 7179209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A primate model (Macaca mulatta) to study the pharmacokinetics of heparin and its fractions.
    Fareed J; Kumar A; Rock A; Walenga JM; Davis P
    Semin Thromb Hemost; 1985 Apr; 11(2):138-54. PubMed ID: 4035364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects.
    Tovar AM; Capillé NV; Santos GR; Vairo BC; Oliveira SN; Fonseca RJ; Mourão PA
    Thromb Haemost; 2012 May; 107(5):903-15. PubMed ID: 22437650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bleeding times in rats treated with heparin, heparin fragments of high and low anticoagulant activity and chemically modified heparin fragments of low anticoagulant activity.
    Palm M; Mattsson C; Svahn CM; Weber M
    Thromb Haemost; 1990 Aug; 64(1):127-32. PubMed ID: 2177229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fractionation of heparin by chromatography on immobilized thrombin. Correlation between the anticoagulant activity of the fractions and their content of heparin with high affinity for antithrombin.
    Nordenman B; Björk I
    Thromb Res; 1980 Aug 15-Sep 1; 19(4-5):711-8. PubMed ID: 7444870
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhancement by heparin of thrombin-induced antithrombin III proteolysis: its relation to the molecular weight and anticoagulant activity of heparin.
    Marciniak E; Gora-Maslak G
    Thromb Res; 1982 Nov; 28(3):411-21. PubMed ID: 7179225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of heparin from human mastocytoma tissue.
    Thunberg L; Höök M; Lindahl U; Abildgaard U; Langholm R
    Thromb Haemost; 1980 Dec; 44(3):125-9. PubMed ID: 6781095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.